Trump administration gears up for new tariffs on select drugmakers

Trump plans 100% tariffs as soon as Thursday on drugmakers lacking low price deals, while firms like Pfizer and Eli Lilly get a three year reprieve under prior agreements

Trump plans 100% tariffs as soon as Thursday on drugmakers lacking low price deals, while firms like Pfizer and Eli Lilly get a three year reprieve under prior agreements

Rupee jumps to 93.53 per dollar after RBI curbs speculative trades, bond yields steady, but high oil, foreign outflows and global tensions keep currency risks elevated

In an earlier interaction with CNBC-TV18, the management of V-Mart Retail had highlighted that the second and fourth quarter are generally a lean period for the company. However, they plan on closing the year with growth ranging between 15% to…

The demand in FY27 is likely to be impacted for the cement sector as well. DAM Capital has tempered its volume outlook to 4% for FY27 from the previous year compared to the earlier projection of 7%.

According to Dipan Mehta, Director, Elixir Equities, growth in organised retail is expected to moderate, with revenue expansion driven by store additions but earnings pace slowing from earlier levels. Investors may consider holding existing positions while being selective on fresh…

IndiGo said it has only partially passed on the higher fuel costs to customers in a bid to support demand.

Sun Pharma is among the Indian companies with the highest exposure to branded pharmaceuticals.

Dhanlaxmi Bank’s gross advances grew by nearly 25%, business growth was in the high teens while deposit growth was also above the mid-teen level. The stock though, has declined along with other banking names on expected lines.

For many wealthy investors, the volatility has been an opportunity to buy dips and rebalance investments.

Globalstar shares surge over 20 percent after report Amazon is in talks to buy the satellite firm, a deal that could boost Amazons internet constellation and challenge SpaceX Starlink